Literature DB >> 21158215

Decreased plasma apelin levels in pubertal obese children.

Serkan Tapan1, Emre Tascilar, Ayhan Abaci, Alper Sonmez, Selim Kilic, M Kemal Erbil, Okan Ozcan.   

Abstract

BACKGROUND: Apelin is a recently defined peptide relevant to the mechanism of obesity-related disorders. There has been no report so far about the levels of plasma apelin in obese children.
METHODS: In this study plasma apelin, adiponectin, and high sensitivity C reactive protein levels were investigated in obese (n=32) and nonobese (n=40) children. The effects of pubertal status on the apelin and adiponectin levels were evaluated as well.
RESULTS: When compared to nonobese controls, the obese children had significantly lower plasma apelin (p = 0.004), adiponectin and HDL cholesterol levels (p = 0.001 for both), and higher hs-CRP, triglycerides, insulin and Homeostasis Model Assessment (HOMA-IR) indexes (p < 0.001 for all). The difference between the apelin levels was present only in the pubertal period (p = 0.002).
CONCLUSIONS: The results of the present study indicate that plasma apelin levels are lower in child obesity and pubertal state is an important determinant of plasma apelin levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21158215     DOI: 10.1515/jpem.2010.165

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  9 in total

Review 1.  Apelin, diabetes, and obesity.

Authors:  Isabelle Castan-Laurell; Cédric Dray; Camille Attané; Thibaut Duparc; Claude Knauf; Philippe Valet
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

Review 2.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

3.  Assessment of Serum Concentrations of Ghrelin, Obestatin, Omentin-1, and Apelin in Children with Type 1 Diabetes.

Authors:  Agnieszka Polkowska; Izabela Szczepaniak; Artur Bossowski
Journal:  Biomed Res Int       Date:  2016-01-19       Impact factor: 3.411

4.  The Effect of Estrogen Replacement Therapy on Visceral Fat, Serum Glucose, Lipid Profiles and Apelin Level in Ovariectomized Rats.

Authors:  Parvin Babaei; Adele Dastras; Bahram Soltani Tehrani; Shiva Pourali Roudbaneh
Journal:  J Menopausal Med       Date:  2017-12-29

Review 5.  The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer.

Authors:  Marta B Wysocka; Katarzyna Pietraszek-Gremplewicz; Dorota Nowak
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

6.  Apelin-13 and Asprosin in Adolescents with Anorexia Nervosa and Their Association with Psychometric and Metabolic Variables.

Authors:  Katarzyna Jowik; Monika Dmitrzak-Węglarz; Natalia Pytlińska; Anna Jasińska-Mikołajczyk; Agnieszka Słopień; Marta Tyszkiewicz-Nwafor
Journal:  Nutrients       Date:  2022-09-28       Impact factor: 6.706

7.  Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice.

Authors:  A D Kandasamy; M M Sung; J J Boisvenue; A J Barr; J R B Dyck
Journal:  Nutr Diabetes       Date:  2012-09-10       Impact factor: 5.097

8.  Associations between serum apelin-12 levels and obesity-related markers in Chinese children.

Authors:  Hong-Jun Ba; Hong-Shan Chen; Zhe Su; Min-Lian Du; Qiu-Li Chen; Yan-Hong Li; Hua-Mei Ma
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Relationships of apelin concentration and APLN T-1860C polymorphism with obesity in Thai children.

Authors:  Kanjana Suriyaprom; Banchamaphon Pheungruang; Rungsunn Tungtrongchitr; Orn-Uma Y Sroijit
Journal:  BMC Pediatr       Date:  2020-09-30       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.